Mengya Zang
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 16
-
- Immunotherapy and Immune Responses 5
-
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 4
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 4
-
- Cancer Mechanisms and Therapy 6
-
- Renal cell carcinoma treatment 4
- Cited by
- HepatologyImmunologyOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Mengya Zang
23 papers receiving 503 citations
Peers
Comparison fields: 5 of 68
- Hepatology 199
- Immunology 174
- Oncology 161
- Cancer Research 66
- Epidemiology 109
Countries citing papers authored by Mengya Zang
This map shows the geographic impact of Mengya Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengya Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengya Zang more than expected).
Fields of papers citing papers by Mengya Zang
This network shows the impact of papers produced by Mengya Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengya Zang. The network helps show where Mengya Zang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengya Zang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 28 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 61 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 30 | |
| 15 | 2018 | 43 | |
| 16 | 2017 | 100 | |
| 17 | [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. | 2015 | 3 |
| 18 | 2015 | 22 | |
| 19 | 2013 | 78 | |
| 20 | 2012 | 39 |
About Mengya Zang
Mengya Zang is a scholar working on Hepatology, Pathology and Forensic Medicine and Oncology, having authored 25 papers that have together received 509 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer Mechanisms and Therapy (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Immunotherapy and Immune Responses (5 papers), Hepatitis B Virus Studies (5 papers), Renal cell carcinoma treatment (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Hepatology (199 citations), Immunology (174 citations) and Oncology (161 citations). Mengya Zang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chunfeng Qu, Kun Chen, Jinzhang Chen, Guosheng Yuan, Xiao Hu, Huan He, Dongmei Wang, Zhiyuan Wu, Xiao Cheng and Yabing Guo. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.